Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Sep;7(9):812-26.
doi: 10.1016/S1474-4422(08)70169-8. Epub 2008 Jul 28.

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

Collaborators, Affiliations
Review

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

Raj N Kalaria et al. Lancet Neurol. 2008 Sep.

Erratum in

  • Lancet Neurol. 2008 Oct;7(10):867

Abstract

Despite mortality due to communicable diseases, poverty, and human conflicts, dementia incidence is destined to increase in the developing world in tandem with the ageing population. Current data from developing countries suggest that age-adjusted dementia prevalence estimates in 65 year olds are high (>or=5%) in certain Asian and Latin American countries, but consistently low (1-3%) in India and sub-Saharan Africa; Alzheimer's disease accounts for 60% whereas vascular dementia accounts for approximately 30% of the prevalence. Early-onset familial forms of dementia with single-gene defects occur in Latin America, Asia, and Africa. Illiteracy remains a risk factor for dementia. The APOE epsilon4 allele does not influence dementia progression in sub-Saharan Africans. Vascular factors, such as hypertension and type 2 diabetes, are likely to increase the burden of dementia. Use of traditional diets and medicinal plant extracts might aid prevention and treatment. Dementia costs in developing countries are estimated to be US$73 billion yearly, but care demands social protection, which seems scarce in these regions.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: RPF is a consultant to MIMvista, Inc. AW has been acting as a consultant to drug companies that are purchasing or developing drugs for treatment of Alzheimer's disease or other dementias (Pfizer, Janssen-Cilag, Novartis, Merz, Lundbeck, Forest, GlaxoSmithKline, Wyeth, Sanofi, Elan, Neurochem). All other authors have no conflicts of interest.

Figures

Figure
Figure. Sporadic and familial dementias in developing countries
Red-shaded countries have prevalence or incidence estimates of all dementias that have been determined to be similar (>5%) to those in developed countries (grey-shaded countries). Blue-shaded countries have significantly lower prevalence (<3%) of dementia. Sample sizes for the estimates in the various studies were between 700 and 3200 individuals. Green-shaded areas show countries where there are published cases of dementia or subtypes (AD or VaD), where risk factors have been examined but prevalence or incidence are unknown. Reliable information was not available for countries without shading. Red spots show locations of families with neurodegenerative and vascular disorders causing dementia including AD, Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, Huntington's disease, amyotrophic lateral sclerosis, and CADASIL. Information on dementia prevalence and types was derived from many sources.,,,,–,,,,–,,–

Comment in

References

    1. WHO. Active ageing: a policy framework, 2002 health report. Geneva: World Health Organization; 2002.
    1. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–17. - PMC - PubMed
    1. Suh GH, Shah A. A review of the epidemiological transition in dementia—cross-national comparisons of the indices related to Alzheimer's disease and vascular dementia. Acta Psychiatr Scand. 2001;104:4–11. - PubMed
    1. Raicher I, Shimizu MM, Takahashi DY, et al. Alzheimer's disease diagnosis disclosure in Brazil: a survey of specialized physicians' current practice and attitudes. Int Psychogeriatr. 2008;20:471–81. - PubMed
    1. Wimo A, Jonsson L, Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord. 2006;21:175–81. - PubMed

Publication types

Substances